Huang, Weijun http://orcid.org/0000-0002-2704-4674
Hickson, LaTonya J.
Eirin, Alfonso http://orcid.org/0000-0002-3864-9644
Kirkland, James L. http://orcid.org/0000-0003-1676-4905
Lerman, Lilach O. http://orcid.org/0000-0002-3271-3887
Article History
Accepted: 24 June 2022
First Online: 3 August 2022
Competing interests
: L.O.L. is an adviser to AstraZeneca, CureSpec, Beren, Ribocure Pharmaceuticals and Butterfly Biosciences. Patents on senolytic drugs and their uses are held by the Mayo Clinic. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and was conducted in compliance with Mayo Clinic Conflict of Interest policies. The other authors declare no conflicts of interest.
Free to read: This content has been made available to all.